1. Zhang T#, Yu F#, Xu H, Chen M, Chen X, Guo L, Zhou C, J Yu*, Wu B*. Dysregulation of REV-ERBα impairs GABAergic function and promotes epileptic seizures in preclinical models. Nat Commun. Accepted. (IF: 12.121)
2. Guo L#, Zhang T#, Wang F, Chen X, Xu H, Zhou C, Chen M, Yu F, Wang S, Yang D, Wu B. Targeted inhibition of Rev-erb-α/β limits ferroptosis to ameliorate folic acid-induced acute kidney injury. Br J Pharmacol. 2020. doi: 10.1111/bph.15283. (IF: 7.73)
3. Zhang T, Chen M, Guo L, Yu F, Zhou C, Xu H, Wu B*. REV-ERBα antagonism promotes homocysteine catabolism and ammonia clearance. Hepatology. 2019,70(5):1770-1784. (IF: 14.679)
4 . Zhang T#, Guo L#, Yu F, Chen M, Wu B*. The nuclear receptor Rev-erbα participates in circadian regulation of Ugt2b enzymes in mice. Biochem Pharmacol. 2019,161:89-97. (IF: 4.96)
5.Yu F#, Zhang T#, Zhou C, Xu H, Guo L, Chen M, Wu B*. The Circadian Clock Gene Bmal1 Controls Intestinal Exporter MRP2 and Drug Disposition. Theranostics. 2019, 9(10): 2754-2767. （封面文章）(IF: 8.579)
6. Chen M, Guo L, Dong D, Yu F, Zhang T*, Wu B*. The nuclear receptor Shp regulates morphine withdrawal syndrome via modulation of Ugt2b expression in mice. Biochem Pharmacol. 2019,161:163-172. (IF: 4.96)
7. Chen M#, Guan B#, Xu H, Yu F, Zhang T*, Wu B*. The Molecular Mechanism Regulating Diurnal Rhythm of Flavin-Containing Monooxygenase 5 in Mouse Liver. Drug Metab Dispos. 2019, 47(11):1333-1342. (IF: 3.231)
8. Zhang T, Yu F, Guo L, Chen M, Yuan X, Wu B*. Small Heterodimer Partner Regulates Circadian Cytochromes p450 and Drug-Induced Hepatotoxicity. Theranostics. 2018,8(19):5246-5258. (IF: 8.579)
9. Zhang T#, Zhao M#, Lu D, Wang S, Yu F, Guo L, Wen S, Wu B*. REV-ERBα Regulates CYP7A1 Through Repression of Liver Receptor Homolog-1. Drug Metab Dispos. 2018,46(3):248-258. (IF: 3.231)
10. Yu F#, Zhang T#, Guo L, Wu B*. Liver Receptor Homolog-1 Regulates Organic Anion Transporter 2 and Docetaxel Pharmacokinetics. Drug Metab Dispos. 2018,46(7):980-988. (IF: 3.231)
11. Dong D#, Zhang T#, Lu D#, Liu J, Wu B*. In vitro characterization of belinostat glucuronidation: demonstration of both UGT1A1 and UGT2B7 as the main contributing isozymes. Xenobiotica. 2017,47(4):277-283. (IF: 1.902)
12. Zhang T#, Dong D#, Lu D, Wang S, Wu B*. Cremophor EL-based nanoemulsion enhances transcellular permeation of emodin through glucuronidation reduction in UGT1A1-overexpressing MDCKII cells. Int J Pharm. 2016,501(1-2):190-8. (IF: 4.845)
13. Chen Z#, Zhang T#, Wu B, Zhang X*. Insights into the therapeutic potential of hypoxia-inducible factor-1α small interfering RNA in malignant melanoma delivered via folate-decorated cationic liposomes. Int J Nanomedicine. 2016,11:991-1002. (IF: 4.471)
14. Zhang T#, Wang H#, Ye Y, Zhang X*, Wu B*. Micellar emulsions composed of mPEG-PCL/MCT as novel nanocarriers for systemic delivery of genistein: a comparative study with micelles. Int J Nanomedicine. 2015,10:6175-84. (IF: 4.471)
15. Zhang X#, Zhang T#, Ye Y, Chen H, Sun H, Zhou X, Ma Z, Wu B*. Phospholipid-stabilized mesoporous carbon nanospheres as versatile carriers for systemic delivery of amphiphobic SNX-2112 (a Hsp90 inhibitor) with enhanced antitumor effect. Eur J Pharm Biopharm. 2015,94:30-41. (IF: 4.604)
16. Zhang X#, Zhang T#, Zhou X, Liu H, Sun H, Ma Z, Wu B*. Enhancement of oral bioavailability of tripterine through lipid nanospheres: preparation, characterization, and absorption evaluation. J Pharm Sci. 2014,103(6):1711-9. (IF: 2.997)
